anti glp 1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Cited in 1 publication Anti-GLP-1 antibody [EPR4042-407] (ab111125) |
Pay in 4 interest-free payments of $6.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
![anti glp 1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Cited in 1 publication Anti-GLP-1 antibody [EPR4042-407] (ab111125) |](https://content.abcam.com/products/images/glp-1-antibody-epr4042-407-ab111125--immunohistochemistry-formalin-pfa-fixed-paraffin-embedded-sections-img113733.jpg)
![anti glp 1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Cited in 1 publication Anti-GLP-1 antibody [EPR4042-407] (ab111125) |](https://content.abcam.com/products/images/glp-1-antibody-24h1l3-ab200474--western-blot-img44844.jpg)
















:max_bytes(150000):strip_icc()/Health-GettyImages-2187000770-0677e00e83464cab947191790a5ef595.jpg)





